YP, C., YC, C., PN, C., YJ, F., CY, C., WY, K., . . . CH, L. (2026). Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease. Gut. https://doi.org/10.1136/gutjnl-2025-337275
Chicago Style (17th ed.) CitationYP, Chang, et al. "Steatosis Grade and Cardiometabolic Burden as Determinants of Hepatocellular Carcinoma Risk After Hepatitis C Cure in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease." Gut 2026. https://doi.org/10.1136/gutjnl-2025-337275.
MLA (9th ed.) CitationYP, Chang, et al. "Steatosis Grade and Cardiometabolic Burden as Determinants of Hepatocellular Carcinoma Risk After Hepatitis C Cure in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease." Gut, 2026, https://doi.org/10.1136/gutjnl-2025-337275.